Literature DB >> 11307496

[Arachidonic acid and prostaglandins, inflammation and oncology].

P Eschwège1, V de Ledinghen, T Camilli, S Kulkarni, G Dalbagni, S Droupy, A Jardin, G Benoît, B B Weksler.   

Abstract

CYCLOOXYGENASE PATHWAY: Among the 3 metabolic pathways leading to oxidation of arachidonic acid, the cyclooxygenase (COX) pathway produces prostaglandin G2 that is rapidly transformed into prostaglandin H2. PROSTAGLANDINS: Prostaglandins are inflammation mediators that are strongly implicated in tumorgenesis. They participate in tumor initiation, promotion and growth. INFLAMMATION AND EPITHELIAL CANCER: Chronic inflammation is a risk factor for epithelial cancer. It induces prostaglandin synthesis via activation of COX-2. There is a cause and effect relationship between chronic inflammation and carcinogeneis via COX-2 expression. It has been demonstrated that COX-2 favors tumor invasion and inhibits apoptosis. Tumor growth is favored by PGE2-induced reduction in immunity; COX-2 inhibitors reinforce the immune response. Finally COX-2 is expressed in tumor neovessels and plays a role in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11307496

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  The effects of cyclooxygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer cells.

Authors:  Yingqiang Zhong; Zhongsheng Xia; Juan Liu; Ying Lin; Hui Zan
Journal:  Oncol Rep       Date:  2011-12-19       Impact factor: 3.906

2.  Evaluation of anti-inflammatory, analgesic, and antipyretic activities of the ethanol extract from Murdannia loriformis (Hassk.) Rolla Rao et Kammathy.

Authors:  Phraepakaporn Kunnaja; Somsakul Pop Wongpalee; Ampai Panthong
Journal:  Bioimpacts       Date:  2014-12-27

3.  Expression of nm23-H1 and COX-2 in thyroid papillary carcinoma and microcarcinoma.

Authors:  Marija Milkovic Perisa; Bozena Sarcevic; Koraljka Gall Troselj; Kresimir Grsic; Sanda Sitic; Sven Seiwerth
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

4.  Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma.

Authors:  Hongyan Zhu; Weili Han; Ye Gan; Qiaofeng Li; Xiaolan Li; Lanlan Shao; Dan Zhu; Hongwei Guo
Journal:  Pharmaceutics       Date:  2019-12-15       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.